Barclays Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $372
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok has maintained an Equal-Weight rating on Molina Healthcare (NYSE:MOH) and raised the price target from $359 to $372.
October 25, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Andrew Mok has maintained an Equal-Weight rating on Molina Healthcare and increased the price target from $359 to $372, indicating a positive outlook.
The increase in the price target from $359 to $372 by Barclays suggests a positive outlook for Molina Healthcare, which could lead to a short-term increase in stock price. The maintained Equal-Weight rating indicates a balanced view, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100